Details for New Drug Application (NDA): 005963
NDA 005963 describes SODIUM SULAMYD, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the SODIUM SULAMYD profile page.
The generic ingredient in SODIUM SULAMYD is sulfacetamide sodium. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
The generic ingredient in SODIUM SULAMYD is sulfacetamide sodium. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 005963
| Tradename: | SODIUM SULAMYD |
| Applicant: | Schering |
| Ingredient: | sulfacetamide sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 005963
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 30% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
